Guillain-Barré syndrome (GBS), the most common cause of acute flaccid paralysis, is a rare condition in which a person’s immune system attacks the peripheral nerves. The symptoms of Guillain–Barré syndrome are numbness, tingling, pain and weakness of the legs and arms.
Guillain-Barré syndrome is due to the nerve dysfunction by an immune attack on the nerve cells of the peripheral nervous system. Different types of Guillain-Barré syndrome are categorized by different types of immune attack. For instance, the demyelinating variant is characterized by the damage to the myelin sheath from white blood cells preceded by the activation of a group of blood proteins. The axonal variant is mediated by the IgG antibodies and the complement components against the cell membrane covering the axons.
Fig.1 Immune system attacks nerves in the body with Guillain-Barre syndrome.
Creative Biolabs offers a series of research tools needed to study the mechanisms of Guillain-Barré syndrome. Some tools, such as autoimmune neuritis animal models, kinase enzymes and complement inhibitors, proteins and antibodies, have been verified in laboratory tests.
Pathways related to Guillain-Barre Syndrome
|Measles||TNF, HLA-DRB1, HLA-DQB1, HLA-DQA1, FAS|
|Herpes simplex virus 1 infection||TNF, HLA-DRB1, HLA-DQB1, HLA-DQA1, FAS|
|Allograft rejection||TNF, HLA-DRB1, HLA-DQB1, HLA-DQA1, FAS, CD40LG|
|NF-kappa B signaling||TNFRSF1B, TNF, FAS, CD79A, CD40LG|
|ICos-ICosL pathway in T-helper cell||HLA-DRB1, HLA-DQB1, HLA-DQA1, CD40LG|
Cellular components related to Guillain-Barre Syndrome
|External side of plasma membrane||TNF, MOG, HLA-DRB1, CD79A, CD40LG|
|Membrane raft||TNFRSF1B, TNF, FAS, CD79A|
|Endocytic vesicle membrane||HLA-DRB1, HLA-DQB1, HLA-DQA1|
|Myelin sheath||PMP2, MPZ, MBP|